Stockreport

Melinta Therapeutics: sNDA Acceptance Triggers 200% Gain [Seeking Alpha]

MELINTA THERAPEUTICS INC  (MLNT) 
Last melinta therapeutics inc earnings: 11/12 04:39 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.melinta.com/investor-relations
PDF Melinta Therapeutics: sNDA Acceptance Triggers 200% Gain Summary Melinta Therapeutics stock rockets as a result of BAXDELA's sNDA being accepted by the FDA for a priorit [Read more]